HEALIUS LIMITED — Director's Dealing 2013

Oct 16, 2013

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Name of Entity PRIMARY HEALTH CARE LIMITED

ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Henry Bateman

Date of last notice 25 September 2013

Date of last notice 25 September 2013	Date of last notice 25 September 2013
Part 1 - Change of director’s relevant interests in securities Inthe case of a trust, this includes interests inthe trust made available by the responsible entity of the trust
Direct or indirect interest	As shown
Nature of indirect interest (including registered holder)	Not applicable
Date of change	15 October 2013
No. of securities held prior to change	627,547 Henry Bateman 9,966 637,513 Florida Road Pty Ltd Ordinary shares
Class	Fully paid ordinary shares
Number acquired	227
Number disposed	NIL
Value/Consideration	$4.833 (DRP)
No. of securities held after change	627,547 Henry Bateman 10,193 637,740 Florida Road Pty Ltd Ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Dividend Reinvestment Plan

Part 2 – Change of director’s interests in contracts Not applicable Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a Not applicable closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during Not applicable this period? If prior written clearance was provided, on what date was this provided? Not applicable

YD CACHIA Company Secretary Date: 17 October 2013

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002